NCT02158091 2026-02-13A Phase 1b/2 Study of IPI-145 Plus FCR in Previously Untreated, Younger Patients With CLLDana-Farber Cancer InstitutePhase 1/2 Active not recruiting32 enrolled 11 charts
NCT03961672 2026-01-05Intermittent Duvelisib Dosing in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCity of Hope Medical CenterPhase 2 Active not recruiting15 enrolled 13 charts